Salem Investment Counselors’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SMTI
SWM
EFA
PFSRSONJ
EWA
IA
Salem Investment Counselors's SMTI Position: Q2 2026 in Review
Salem Investment Counselors reduced its Sanara MedTech (SMTI) stake by 47% in Q2 2026, selling an estimated $187K and leaving 10,134 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #384.
Salem Investment Counselors first reported a position in SMTI in Q1 2021 and has held it in 22 quarters since. The position peaked at $545K in Q1 2023. 20 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.
- Salem Investment Counselors held 10,134 shares of Sanara MedTech worth $239K as of Q2 2026.
- Salem Investment Counselors sold 9,066 Sanara MedTech shares in Q2 2026, an estimated $187K.
- Sanara MedTech made up 0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #384 holding.
- Salem Investment Counselors first reported a position in Sanara MedTech in Q1 2021 and has held it in 22 quarters since.
- Salem Investment Counselors's Sanara MedTech position peaked at $545K in Q1 2023.
- 20 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.